Tickers: XTSX:VPT, PINX:VPTDF
Tags: Technology, Healthcare
Toronto, Ontario / TheNewswire / March 6, 2019 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSXV:VPT) announces a correction to the press release dated March 6, 2019 entitled "Ventripoint Announces Extension of Warrants".
The original press release stated that the extended expiry dates of common share purchase warrants previously issued by the Corporation (the "Warrants") would be in the year 2020, whereas the Corporation intends to extend the expiry dates of the Warrants to 2021, as follows:
Date of Issuance | Number of Warrants Outstanding | Expiry Date | Amended Expiry Date | Exercise Price (not amended) |
March 21, 2017 | 1,575,000 | March 21, 2019 | March 21, 2021 | $0.50 |
March 23, 2017 | 10,496,938 | March 23, 2019 | March 23, 2021 | $0.50 |
For Further Information, Contact:
George Adams, CEO
T: (206) 910-9125
Forward Looking Statement:
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking information or statements. In particular, this news release contains forward-looking information relating to the proposed amendment of the Warrants. The forward-looking statements and information are based on certain key expectations and assumptions made by the Corporation, including expectations and assumptions concerning the completion of the amendment of the Warrants. Although the Corporation believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward looking statements and information because the Corporation can give no assurance that they will prove to be correct.
Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Such factors may include the failure of the Corporation to successfully satisfy certain conditions in connection with the amendment of the Warrants and failure to complete the amendment of the Warrants. Other factors which could materially affect such forward-looking information are described in the risk factors in the Corporation's most recent annual management's discussion and analysis that is available on the Corporation's profile on SEDAR at www.sedar.com. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements included in this news release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this news release are made as of the date hereof and the Corporation undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Copyright (c) 2019 TheNewswire - All rights reserved.
